New York, NY, United States of America

Yoshiyuki Fukase

USPTO Granted Patents = 16 

 

Average Co-Inventor Count = 9.8

ph-index = 3

Forward Citations = 27(Granted Patents)


Location History:

  • Osaka, JP (2010 - 2013)
  • Kanagawa, JP (2015)
  • Fujisawa, JP (2017)
  • New York, NY (US) (2016 - 2023)

Company Filing History:


Years Active: 2010-2023

Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents

Title: Innovations of Yoshiyuki Fukase

Introduction

Yoshiyuki Fukase is a prominent inventor based in New York, NY, known for his significant contributions to the field of pharmaceutical sciences. He holds a total of 16 patents, showcasing his innovative spirit and dedication to advancing medical research.

Latest Patents

Fukase's latest patents include "Heterocyclic amide compounds having an RORγt inhibitory action," which relates to compound (I) or a salt thereof that exhibits RORγt inhibitory action. The formula (I) includes symbols defined in the specification. Another notable patent is "Heterocyclic amide compounds having RORγT inhibitory action," which also pertains to compound (I) or a salt thereof with RORγT inhibitory action, with the formula (I) similarly defined.

Career Highlights

Fukase is currently associated with Takeda Pharmaceutical Company Limited, where he continues to push the boundaries of pharmaceutical innovation. His work has been instrumental in developing new therapeutic compounds that have the potential to improve patient outcomes.

Collaborations

Fukase collaborates with esteemed colleagues such as Satoshi Yamamoto and Junya Shirai, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Yoshiyuki Fukase's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a key innovator in the industry. His work continues to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…